Skip to main content

Advertisement

Figure 1 | BMC Gastroenterology

Figure 1

From: Clinical characteristics of elderly patients with proton pump inhibitor-refractory non-erosive reflux disease from the G-PRIDE study who responded to rikkunshito

Figure 1

Patients enrolled in this study. Of 242 patients with a clinical diagnosis of PPI-refractory NERD, 95 were elderly patients (≥65 years) with ARD. ARD, acid-related dysmotility symptom; RKT group: rikkunshito (7.5 g/day 3 times) + rabeprazole (10 mg/day), PL group: placebo (7.5 g/day 3 times) + rabeprazole (10 mg/day).

Back to article page